Novo Nordisk A/S: Obesity trials

The registry lists 175 Obesity studies with Novo Nordisk A/S as lead sponsor. 49 are open to participants now and 32 have results posted.

Phase 1 67Phase 2 12Phase 3 57Phase 4 3No phase 37(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real WorldCompletedNCT06874751
• Prevalence of Weight Related Complications Across Diverse Weight Classifications - A Large Study in India, Pakistan, Philippines and VietnamCompletedNCT06843473
• A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants After 10 Days of Oral DosingCompletedNCT06820476Phase 1
• A Study Collecting Remote Data in People With an Overweight Condition or Obesity on a Weight Management ProgramCompletedNCT06805539
• A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With ObesityActive, not recruitingNCT06780449Phase 3
• A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or ObesityCompletedNCT06737536Phase 1
• A Study on How NNC0174-1213 Works in People With Overweight or Obesity.CompletedNCT06719011Phase 1
• A Research Study Comparing Different Ways of Increasing the Dose of NNC0519-0130 in Participants With Overweight or ObesityCompletedNCT06718998Phase 1
• A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or ObesityCompletedNCT06716307Phase 1
• A Research Study to Compare How Much of the Medicine NNC0519-0130 is in the Blood of People With Overweight or Obesity Who Receive 2 Preparations of the MedicineCompletedNCT06642571Phase 1
• A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or ObesityActive, not recruitingNCT06577766Phase 1
• STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight LossActive, not recruitingNCT06571383Phase 4
• A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 DiabetesCompletedNCT06567041Phase 1
• A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian MenCompletedNCT06542536Phase 1
• A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or ObesityCompletedNCT06478563Phase 1
• A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose WeightCompletedNCT06388187Phase 3
• A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose WeightCompletedNCT06326060Phase 2
• A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body WeightCompletedNCT06289504Phase 1
• Prevalence and Economic Burden of Obesity-related Comorbidities in the Gulf Region: A Retrospective, Observational StudyCompletedNCT06288399
• Special Use - Results Surveillance on Long-term Use With Wegovy®Active, not recruitingNCT06283667
• Study to Evaluate the Safety and Effectiveness of Saxenda® for Weight Management in Routine Clinical Practice in Taiwan.CompletedNCT06283641
• A Study of How CagriSema Works on Appetite in People With Excess Body WeightCompletedNCT06267092Phase 1
• A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body WeightCompletedNCT06207877Phase 1
• A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose WeightCompletedNCT06131437Phase 3
• A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and PlaceboCompletedNCT06131372Phase 2
• A Research Study to See How a New Medicine (NNC0487-0111) Works in People With Overweight or Obesity When Injected Under the SkinCompletedNCT06064006Phase 2
• A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With ObesityCompletedNCT06049329Phase 1
• A Research Study to See How Well CagriSema Helps People in China With Excess Body Weight Lose WeightCompletedNCT05996848Phase 3
• Study of INV-202 in Patients With Obesity and Metabolic SyndromeCompletedNCT05891834Phase 2
• Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)CompletedNCT05890976Phase 3
• A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular DiseaseCompletedNCT05873660
• A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose WeightCompletedNCT05813925Phase 3
• A Study to Understand the Distribution of Obesity Classes and Obesity Related Diseases in People With Obesity Across Countries in Czech Republic, Hungary and PolandCompletedNCT05795166
• Persons With Obesity (PwO) Exploratory ResearchCompletedNCT05736120
• A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose WeightActive, not recruitingNCT05726227Phase 3
• Awareness, Care & Treatment In Obesity ManagementCompletedNCT05690789
• Obesity and Cardiovascular Diseases, Cross-sectional Study in Saudi ArabiaCompletedNCT05642533
• A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose WeightActive, not recruitingNCT05567796Phase 3
• Awareness, Care & Treatment In Obesity Management - An Observation in Mainland ChinaCompletedNCT05428501
• A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose WeightCompletedNCT05394519Phase 3
• A Research Study on How NNC0487-0111 Works in People With Overweight or ObesityCompletedNCT05369390Phase 1
• A Research Study of How NNC0174-0833 Behaves in Chinese Volunteers Who Are Normal Weight, Overweight or With ObesityCompletedNCT05254158Phase 1
• Awareness, Care & Treatment In Obesity Management - An Observation in Asia PacificCompletedNCT05250427
• A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With ObesityCompletedNCT05236517Phase 1
• Awareness, Care & Treatment In Obesity Management - An Observation in SwitzerlandCompletedNCT05232786
• Awareness, Care & Treatment In Obesity Management - An International Observation Among Teens (ACTION Teens)CompletedNCT05013359
• SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes TrialCompletedNCT04972721
• A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or ObesityCompletedNCT04940078Phase 1
• SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With ObesityActive, not recruitingNCT04775082Phase 3
• A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of SemaglutideCompletedNCT04228354Phase 1
• A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or ObesityCompletedNCT04187300Phase 1
• A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or ObesityTerminatedNCT04012255Phase 1
• A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or ObesityCompletedNCT04010786Phase 1
• A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With ObesityCompletedNCT03842202Phase 1
• A Research Study of How NNC0174-0833 Behaves in Japanese and Caucasian Volunteers Who Are Normal Weight, Overweight or With ObesityCompletedNCT03787225Phase 1
• A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or ObeseCompletedNCT03707990Phase 1
• Research Study of a New Medicine (NNC9204-1706) in People With Overweight or ObesityCompletedNCT03661879Phase 1
• A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or ObeseCompletedNCT03600480Phase 1
• Awareness, Care & Treatment In Obesity Management - An International ObservationCompletedNCT03584191
• A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or ObeseCompletedNCT03574584Phase 1
• A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.CompletedNCT03560336
• A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or ObesityCompletedNCT03479892Phase 1
• Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)CompletedNCT03430154
• Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or ObesityCompletedNCT03308721Phase 1
• Awareness, Care and Treatment in Obesity ManagementCompletedNCT03235102
• Awareness, Care & Treatment in Obesity Management (ACTION) StudyCompletedNCT03223493
• Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With ObesityCompletedNCT03095807Phase 1
• First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or ObesityCompletedNCT03015207Phase 1
• Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or OverweightCompletedNCT02958085Phase 1
• A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.CompletedNCT02941042Phase 1
• Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With ObesityCompletedNCT02870231Phase 1
• A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With ObesityCompletedNCT02835235Phase 1
• Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican PatientsCompletedNCT02773355
• A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses and Multiple Doses of NNC0165-1562 in Overweight to Obese But Otherwise Healthy SubjectsCompletedNCT02568306Phase 1
• A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy VolunteersTerminatedNCT01044108Phase 1